Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Mycoplasma Testing Market?

In recent years, the mycoplasma testing market has seen substantial growth. The market size, which was at $1.08 billion in 2024, is projected to reach $1.23 billion by 2025, representing a 13.7% compound annual growth rate (CAGR). The historical growth period witnessed numerous factors including outbreaks and contamination mishaps, greater public awareness, the proliferation of the biotechnology sector, R&D efforts, healthcare sector trends, and the increased output in cell culture production.

What Growth Rate Is Forecasted for the Mycoplasma Testing Market by 2029?

The market size for mycoplasma testing is set to experience a significant upswing in the coming years. It is projected to expand to $1.92 billion by 2029, sustaining a compound annual growth rate (CAGR) of 11.7%. The anticipated escalation in this period can be linked to the need for quality assurance, the emergence of new markets, the expansion of the biopharmaceutical sphere, the surge in cell-based therapies, and the development of the biotechnology sector. Key trends to look out for during this forecast period will be regulatory norms and adherence, awareness around healthcare and diagnostics, readiness for global pandemics, innovation in point-of-care testing, and stronger market presence in burgeoning economies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=4103&type=smp

Which Key Companies Are Shaping the Future of the Mycoplasma Testing Market?

Major companies operating in the mycoplasma testing market include Abbott Laboratories, Merck KGaA, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Lonza Group AG, Roche Diagnostics International AG, Charles River Laboratories International Inc., Nelson Laboratories Fairfield Inc., Creative Bioarray, Biological Industries Israel Beit Haemek Ltd., Biotools B & M Labs S.A, PromoCell GmbH, American Type Culture Collection, Bionique Testing Laboratories Inc., InvivoGen, Clongen Laboratories LLC, Norgen Biotek Corporation, Gen Bio Sciences (P) Ltd., GeneCopoeia Inc., Minerva Biolabs GmbH, Mycoplasma Experience, Savyon Diagnostics, ScienCell Research Laboratories Inc.

Which Factors Are Driving Demand in the Mycoplasma Testing Industry?

The rising occurrence of mycoplasma pneumonia is predicted to drive the expansion of the mycoplasma testing market in the future. Mycoplasma pneumonia is a respiratory infection that happens due to the bacteria Mycoplasma pneumoniae. The significance of mycoplasma testing is seen in the diagnosis of Mycoplasma pneumonia as it identifies the presense of the Mycoplasma pneumoniae bacteria in respiratory samples, thereby assisting in precise and prompt recognition of the infection for the right medical treatment and handling. For example, the Centers for Disease Control and Prevention, a government agency in the US, estimated in December 2023 that there are about 2 million cases of Mycoplasma pneumoniae infections happening annually in the United States. Consequently, the escalating prevalence of mycoplasma pneumonia is a key driving factor in the growth of the mycoplasma testing market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=4103&type=smp

How Is the Mycoplasma Testing Market Segmented by Several Divisions?

The mycoplasma testing market covered in this report is segmented –

1) By Product: Instruments, Assay, Kits, and Reagents

2) By Technology: PCR, ELISA, Enzymatic Methods, DNA Staining, Other Technologies

3) By Application: Cell line Testing, Virus Testing, End- of- Production Cell Testing

4) By End User: Pharmaceutical & Biotechnology Companies, Cell Banks & Laboratories, Contract Research Organizations, Academic Research Institutes

Subsegments:

1) By Instruments: Mycoplasma Detection Systems, Automated Test Equipment, PCR Equipment

2) By Assay: Mycoplasma Assays (PCR-Based, Culture-Based), Qualitative Assays, Quantitative Assays

3) By Kits: Mycoplasma Detection Kits, Mycoplasma Testing Kits for Cell Cultures, Sample Preparation Kits

4) By Reagents: Nucleic Acid Reagents, Cell Culture Reagents, Staining Reagents

What are the Emerging Market Trends Driving the Growth of the Mycoplasma Testing Industry?

Key market participants are actively engaging in strategic endeavours like launching novel products, progressing in research and development sectors, and fostering technological innovations. These steps are significantly contributing to their prominence in the mycoplasma testing market. By introducing groundbreaking products, these companies aspire to cater to the needs of end users and grow their customer base, ensuring their survival in the competitive market landscape. In an instance from October 2022, SwiftDx, a biotech firm based in the UK, introduced a new mycoplasma contamination detection test utilizing a PCR-based approach. The SwiftDx Mycoplasma Detection Kit is a simple yet precise lateral flow test for mycoplasma detection. The test entails using a small specimen directly from the cell culture media supernatant without causing any disruption to the cell growth. The outcomes are presented in a straightforward, easy-to-understand manner. Possessing a high sensitivity and specificity, the test has a detection limit below 10 cfu/mL after the third day of culture.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/mycoplasma-testing-global-market-report

Which Regions Are Driving Growth in the Mycoplasma Testing Market?

North America was the largest region in the mycoplasma testing market in 2024. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the mycoplasma testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=4103

This Report Delivers Insight On:

1. How big is the mycoplasma testing market, and how is it changing globally?

2. Who are the major companies in the mycoplasma testing market, and how are they performing?

3. What are the key opportunities and risks in the mycoplasma testing market right now?

4. Which products or customer segments are growing the most in the mycoplasma testing market?

5. What factors are helping or slowing down the growth of the mycoplasma testing market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model